Recruiting
Peripheral T-cell lymphoma unspecified+1
RecruitingStudy on Azacitidine, Roginolisib, and Golcadomide for Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas
Registered drugNo placebo
Study on Azacitidine, Roginolisib, and Golcadomide for Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas
Registered drugNo placebo
- Disease:Peripheral T-cell lymphoma unspecifiedPeripheral T-cell lymphoma unspecified refractory
- Substances:AzacitidineGolcadomide+2
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Azacitidine
- Sponsor:LYSARC